RE:On going Goblet next armYep, with Onc anything IS possible. But very little is EVER delivered.
Whilst this additional trial is welcome, as you correctly point out Canaduh, Folfirinox in itself (as most chemo) is harmful to the patient.
Pela may well be safe and tolerated, but they are still being given Chemo... this may be why potential suitors are put off... and instead chase therapies that don't still rely on chemo.
I think all shareholders deserve some answers as to HOW ONCY is going to pay for either of their "phase III" trials. Before rasing funds gets too ugly.